Professional Documents
Culture Documents
PDF Extracorporeal Life Support The Elso Red Book Thomas V Brogan Ebook Full Chapter
PDF Extracorporeal Life Support The Elso Red Book Thomas V Brogan Ebook Full Chapter
https://textbookfull.com/product/basic-life-support-provider-
manual-mary-fran-hazinski/
https://textbookfull.com/product/global-catastrophic-biological-
risks-thomas-v-inglesby/
https://textbookfull.com/product/secured-by-the-seal-red-white-
and-built-book-5-ericson-carol/
https://textbookfull.com/product/the-multiple-realization-book-
thomas-w-polger/
Red, White & Bang (Falling On The Fourth Book 4) 1st
Edition M.K. Moore [Moore
https://textbookfull.com/product/red-white-bang-falling-on-the-
fourth-book-4-1st-edition-m-k-moore-moore/
https://textbookfull.com/product/history-of-war-book-of-the-red-
coats-4th-edition-2021-april-madden-editor/
https://textbookfull.com/product/atls-advanced-trauma-life-
support-student-course-manual-american-college-of-surgeons/
https://textbookfull.com/product/mission-mars-the-thrilling-
history-of-the-red-planet-destination-outer-space-book-2-john-
hamilton/
https://textbookfull.com/product/red-dwarfs-their-geological-
chemical-and-biological-potential-for-life-david-s-stevenson/
Table of Contents
Dedication ............. 1$ • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 8 •••• V
th
Preface to the 5 Edition ............................................................................................... xvii
2. The
................................................................................................ 26
ELSO .......................................................................................... 27
South and West Asian ELSO .............................................................................. 28
References ............................................................................................................ 29
4. The Physiology of Extracorporeal Life Support .....................................................31
Cardiopulmonary Physiology ............................................................................... 31
Cardiopulmonary Pathophysiology ......................................................................33
Cardiopulmonary Pathophysiology during ECMO
The ECMO Circuit. ............................................................................................. 34
Modes and .............................................................36
lastl.cmlrs ..................................................................................... 51
ECLS Circuit Components ...................................................................................52
Table ofContents
xx
Table o/Contents
1
Contraindications
Weight kg ...................................................................................................... 154
Gestational Age wks ................................................................................... 154
iemorrtlage ..................................................................................... 155
.......................................................................................................... 175
Errors of Metabolism .............................................................................. 176
Abnormalities ........................................................................................ 176
xxi
Table ofContents
Cardiovascular .................................................................................................. .
Neurologica1. ...................................................................................................... 204
Fluid JJu,Jt.....""v.L'-VJUu,u
XXIl
Table ojContents
Failure
Asthmaticus
The Inununocompromised ..................................................................................233
MediastmallH'L;);)<O;)
uillionary Hemorrhage .................................................................................. ..
Perioperative Support for .......................................................
Air ................................................................................................ 234
Preoperative Rehabilitation ............
References ........................................................................................................... 23 7
Contraindications in Children with Respiratory Failure .......... 239
239
:ontramlOlC'ltIODS ................................................................................................ 242
244
244
Preferred Routes
Technique ........................................................................................................... 248
Complications .....................................................................................................252
254
21. Comorbidities ."ULIULU"i!:; Pediatric Patients with Respiratory Failure .................. 255
Hospital n.HULU.\V . . .
276
lLA..d.V1.\J .........................................................................................
xxiii
Table ofContents
XXlV
Table ofContents
Stabilization ................................................................................. .
1-'ft>",r"'1"",fn'l>
Cardiac ,"-"WlHILU<U,lVLl
347
,"-"WlLU"ll(n,lVLl . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
References.......................................................................................................... 364
Medical Management of Neonates & Children with Cardiovascular Disease •.367
Introduction.........................................................................................................367
Utilization ECLS
xxv
Table a/Contents
Longt;:r-tl~rm Survival
Early Neurological Outcome
LOJl1ge:r-u~rm Neurodevelopmental Outcome ...................................................... 397
Long-term Quality ofLife (QOL)
FoUowup ............................................................................................................ 398
References........................................................................................................... 401
XXVl
Table ofContents
37. Indications & Contraindications in Adults with Respiratory Failure .............. 415
15
424
38. ECLS Cannulation for Adults with Respiratory Failure ...................................
Comorbidities
Comorbidities lOemUlOO
Impact of Comorbidities on Outcome
Specific Common Comorbidities and Their with ECLS ................. .442
Summary............................................................................................................ 444
Prone I:'matlClnIrlg
Bronchoscopy .................................................................................................... 450
Airway 450
Tracheostomy 1
Awake 1
Cardiovascular Vasopressors and 1
xxvii
Table a/Contents
xxviii
Table ofContents
xxix
Table ofContents
xxx
Table oJContents
51. The Weaning Process and Decannulation in Adult Cardiac Patients ............... 569
569
Echocardiography in the Weaning t'rocess ... . 570
Decannulation .................................................................................................... .
VA-BCMO Decannulation
I..irnpropn'!" BCMO JJVV<WJLU ...................................................................... 572
Conclusion ..........................................................................................................572
References ...........................................................................................................573
Neurologic and Pulmonary Complications Adult ECLS ............................... 575
57. Extracorporeal Life for Severe Cardiotoxic Drug Poisoning .............." ...
Introduction.........................................................................................................627
ECLS for Poisoning-induced Cardiovascular Failure .......................................627
Venovenous Poisoning-induced Respiratory
Conclusion
634
58. ECMO as Bridge to Lung Transplantation ......................................................... 639
Introduction ........................................................................................................ 639
..................................................................................... 639
ECMO
61. Procedures on
679
Questions ................................................................ 680
General Principals .............................................................................................. 680
General Measures ............................................................................................... 681
ECMO Related Procedw
Ul~l!mostlc Procedures
Procedures General ...............................................................................683
and Burn P"t;""t"
Specific Surgical Procedures in Respiratory ECMO .......................................... 687
Specific Surgical Procedures in Cardiac .................................................. 687
Conclusion ........................................................................................................ .
62. Extracorporean EUmmation ..........'..............................,................,....'...............·............. \j'7
Acute Kidney (AKJ)
Apheresis during 701
References.......................................................................................................... 708
63. Extracorporeal Carbon Dioxide Removal ........................................................... 713
718
Intraaortic J.JU.UV~'H
IMPELLA ...........................................................................................................723
Levitronix ........................................................................................ 724
Anticoagulation ...................................................................................................725
Right Ventricular
xxxm
Table ofContents
xxxiv
lable
769
770
69. The Economics of ECMO...................................................................................... 773
Pharmacokinetics ................................................................................................795
Pharmacokinetic Changes Critical Illness ECLS ..................................... 797
Experience and Recommendations Based on Medication Class ....................... 798
General Strategy
References ...........................................................................................................806
72. The of the Extracorporeal Life Support Organization ....................... 809
Data Collection ................................................................................... 810
Registry ................................................................................................. 811
Current Data Summary 12
Neonatal Trends ..................................................................................................812
Pediatric Trends .................................................................................................. 812
Adult Trends ........................................................................................................812
Cardiac Trends
Summary
814
Glossary 815
9 ..................................................................................................................................
xxxv
1
"During that long night, helplessly watching blood driven by a syringe to the right heart
the patient struggle for life as her blood became to generate circulation in an animal
darker ... the idea naturally occurred to me that model. Results promising, but limited by
ifit were possible to remove continuously some lack of UU"'V"'UF.'L"U~'VJU, leading Richardson to
ofthe blue blood... put oxygen into that blood. .. ':t"'I'<ltll'n [and artificial
and then to inject continuously the now-red v,.,,,,,,,.v,,,, process, and that it
blood back into the patient s arteries, we might el~ments oftime, experiment
have saved her life". development of a demon
-.John Gibbon MD
UIV'UVlli
-
science."2 In the 1920's
. Brukhonenko and
1
Chapter 1
Figure 1-2. John H. Gibbon MD and patient Cecilia Bavolek, who the landmark repair in
1953 of an atrial septal defect utilizing an extracorporeal circuit. The two before the Plexiglas-
covered "lung" ten years after the procedure. Right: original device, Upt"V"1.Uf"""" J the size ofa spinet
piano (source: Jefferson University Archives).
2
The History and )ev'elo'plf/ent ofExtracorporeai Support
the invention of silicone and the ability to al less heparin would
low prolonged circuit-blood exposure through showed circuits could be
controlled anticoagulation.8 The development of clot formation or hem or
synthesis of silicone rubber by Kammermeyer Drinker also described
in 1957. revolutionized the artificial lung. 8,9 approach to continuously
Silicone possessed the strength to withstand "'V':l~U"aLJVp and heparin dosing via the
hydrostatic pressure and yet remain permeable a time honored approach
to gas transfer, Collaborative innovators, in place for over 40 years.?
cluding Drs, Theodor Kolobow, Al Gazzaniga, extracorporeal support
Phil Drinker, and Robert Bartlett pioneered and recovery postopera
experiments in developing a silicone membrane congenital heart disease
lung that allowed prolonged circulation l . Kolff nh'VC;:1/~j""c;: to expand its operating
and Kolobow independently identified and ad al. 13 first reported the use
vanced the use of silicone membranes for gas for surgery itself,
exchange, and Kolobow identified the enhanced from other centers. In
gas exchange activity of a spiral-wrapped and
silicone membrane. 9,lo The use of the silicone
"membrane oxygenator" also led to the use of
the term extracorporeal membrane oxygenation tilrr\{'pn,"'pfor correction of
(EeMO). Bypass became feasible in animal great vessels; they subse
models for days at a time. II arr\nl1rnrt series ofcases. 14 In
Bartlett and Drinker also recognized that pa~lents related to low cardiac
the cardiac patient in the operating room needed failure or pulmonary
"infinite" anticoagulation due to stagnation in lowing surgical repair of
open surgical repair, but with long-term cir
Figure 1-3. Bubble oxygenator invented and first use in 1954. Left: Richard DeWall with
device. Right: Dr, C. Walton Lillehei, cardiovascular surgeon and innovator cardiopulmonary bypass.
3
Chapter J
With this improved technology, extracor bedside from the "... ",,."t-n"', and sought consent
poreal support was extended outside of the from the infant's who had delivered her
operating theater. Dr. J.D. Hill reported on the
first successful cannulation and prolonged extra
corporeal circuit use in a patient in an intensiye
care setting in 1972. 15 The patient was a 24-year
old male with a ruptured aorta and posttraumatic
acute respiratory distress syndrome following
a motorcycle accident, and who was supported
with a membrane lung developed by Morrie _5).19,20 Bartlett's success
Bramson. The patient received venoarterial helped drive growing
support for 75 hours, with subsequent decan of use in neonates around
nulation and survival. Adult ECMO support ivors among 16 patients
efforts continued, although survival rates were coworkers, clinical
initially low. outcomes improved,21.23 which
Meanwhile, the use of ECLS in newborns
and neonates also expanded. Dorsons and White
reported experience with trials ofextracorporeal
support l6, 17 in moribund patient cases at the end
of life, demonstrating the capability of the sup
port system to provide adequate oxygenation.
Surgeon Dr. Robert Bartlett (Figure 1-4),
who has been called the father of modern extra
corporeal support, made a therapeutic decision
in 1975 that brought this burgeoning technology
to neonates with primary respiratory conditions.
Faced with a newborn infant dying from meco
nium aspiration pneumonia and resultant pul
monary hypertension, Bartlett and colleagues
brought an ECMO oxygenator to the NICU
4
The H~tmy and Devetopl nt ofExtracorporeai Support
promoted the interest and application in the in neonates. Cente performing ECMO grew
surgical and intensive care community. Pub from only 18 wor dwide to over 100 centers
lished reports showed ongoing improvements in the early 1990 . Thanks to technological
in outcomes, increasing survival rates 75% for advances, neonatal and pediatric application of
neonatal diseases previously associated with ECMO became a c romon practice.
only 10% survival. A second pros ective trial effort took ad
Expansion ofthe use ofECMO in neonates vantage ofECMO d traditional, non-ECMO
ran counter to typical use of new medical and therapy being pro ided in separate intensive
technologic interventions, which had typically care units. Dr. Pear O'Rourke, a pediatric criti
advanced first in adults. With growing interest, cal care physician a Boston Children's Hospital
the medical community sought randomized, (Figure 1-6), led a 0 phase RCT. The study
controlled trial (RCT) evidence ofthe benefits design included a phase one approach with
of neonatal extracorporeal support over stan a traditional 50/50 randomization of patients
dard therapies. Dr. Bartlett and colleagues at the until one arm had four deaths, followed by a
University ofMichigan initiated an ECMO RCT phase two utilizing Ian adaptive design to favor
with an intriguing statistical twist to give pref the ''winner'' of th9 first phase. Overall, 19/20
erence in the trial to a therapy which appeared (97%) ofECMO pa ients survived compared to
superior. Their "randomized play the winner" 60% of standard c ntrol patients. 25 The study,
approach began with randomization but gave published in 1989, engendered controversy in
increased preference based on the success or the medical cOriiin . and in the media.26,27
failure ofthe previous patient. During the study, Ironically, an outc arose from many medical
the first patient receiving ECMO, survived. The professionals and e la ress that randomiza
next patient, randomized to standard care, died. tion to standard th ra without ECMO was
Increased preference went to ECMO, and the a loss of equipoise and
next ten patients, all receiving ECMO, survived recognition that ECMO
(p=.OOOOOOI). The study24 was published in had become a stan d of ~re.
l.2.8..5 to sjgnificant controversy and discussjon, The long-desir d RCT evidence for out
including concern that control patients did not come benefit in ne~atal ECMO for persistent
undergo informed consent. The findings, how pulmonary hypert sion was provided by a
ever, encouraged growing use ofECMO support study performed in he United Kingdom from
1993 to 1995 28 that emains to date the lar est
randomized ECMO trial. The study, authored
by Drs. David Fiel ,Richard Firmin, and col
leagues, enrolled 55 penters and took advantage
of the country's re~' o nalized medical! ECMO
system, with rando ization either to stay in the
referral center for s . ndard therapy or transfer
to the regional EC 0 center. A significant
survival difference (pO% in ECMO patients vs.
40% with standard tperapy; number needed to
treat: 3-4) supported the superiority ofECMO
in neonatal respirat Iry failure, and etched the
value ofECMO in s one.
Figure 1-6. Dr. Pearl O'Rourke, principal
investigator of early neonatal ECMO random
ized trial.
5
Chapter I
l
Table 1-1. Charter Members of First Extra
-~ IUC!
Clinical Re search
UM Mull lcenter
I
Randomized Trials
UM Seminars /
I
/
corporeal Life Supp rt Organization Steering
Committee, 1989
Members
Robert Bartlett
William Kanto
Location
Ann Arbor, MI
Augusta, GA
Fred Ryckman , Cincinnati, OH
/ / RegISl'Y
Larry Cook Louisville, K Y
// Standard
Martin Keszler Washington, DC
-:;7
Treatment
~ Billie Lou Short Washington, DC
·90
P, Pearl O' Rourke Seattl e, WA
1975 ·60 '82 '84 '86 '86
1. DeVil Cornish San Diego, CA
Figure 1-7. Graphic representation of devel Charles Stolar New York, NY
opment and propagation of ECMO, from NIH Michael Klein Detroit, MI
Report ofthe Workshop on Diffusion ofECMO Phyllis McClellan Ann Arbor, MI
Technology, 1993. Sandy Snedecor Ann Arbor, M
6
The History and ofE'xtracorporeal Support
7
Chapter J
be utilized by a growing number of centers. In outcomes with the national and international
addition, it became the steering organization centers. Internationrl ELSO Registry involve
for future randomized trial work. Awards for ment grew from 80 Eenters in 1990 to over 467
ELSO Centers of Excellence were developed active centers in 201 and well over350 ce ers
to provide center recognition around ELSO contributing da~ igure 1-9). From Registry
recommendations. The Award of Excellence inception to date in 017, the Registry database
has received recognition by entities such as the has captured over 8 ,000 atients and provided
annual US News and World Report survey as a data for hundreds 0 ublications and countless
marker of institutional quality. queries for centers eeking experience around
Key efforts of ELSO included the publica ECMO use in a spe ific condition. The Regis
tion of manuals and textbooks to help codify try is the largest re ository of extracorporeal
approaches to ECLS care. The need for a col support data in the orld and is considered the
lated text ofECMO knowledge was recognized. gold standard for r porting U.S. and interna
Two members of the steering committee, Drs. tional ECLS outcomes. Use ofneonatal ECMO
Robert Arensman and Devn Cornish, edited the peaked in 1992 at aroullif 1500 annual cases.
The deveI ofl ~dditionaI new therapies
inaugural edition of this textbook, now known
as the "Red Book," in 1992. The Red Book such as inhaled nitri ~ oxide likely contributed
has now entered its 5th edition in 2016 as a to a decline in the n mbers of neonates requir
collaboration of experts in the global ECMO ing ECMO, to curren levels half of those at the
community. peak of neonatal use
A critical element ofpropagation ofECMO Efforts to use EC MO for pediatric cardiac
technology was the development of a standard and respiratory failw e rose with the success of
ized international patient database to track neonatal ECMO and ts availability in growing
results and provide evaluation of indications numbers of centers. A variety of case series
and outcomes in a large population, a huge supported the effica( y of ECMO in pediatric
improvement over traditional small case series respiratory failure. 32, ~ However, the relatively
experience. This early database, which trans i low numbers of pedi~tric patients suitable for
ECMO across the couptry precluded a definitive
tioned into the ELSO Registry,31 allowed for
participating institutions to collate and compare A
trial. multicenter iT was attempted in the
I!?
G>
C 250
G>
0 200
..
'0
350
300 I':
:I
000 &
000 '0
!
..
G>
.c
E
:>
z
150
100
fo~~
fOoo
i
n
III- Z
50 000
0
8
The History and Developm nt ofExtracorporeal Support
1990s by Fackler and Heulitt, but was stopped dard therapy utili) g a computerized protocol
due to enrollment difficulties, and lower than for ventilator man gement. The study again
expected mortality in the study population. 34 showed no differen in outcomes. Study design
In the absence of a pediatric RCT the most sig concerns included e lack of experience with
nificant case-control study35 demonstrated im extracorporeal use in some centers as well as
proved outcomes associated with use ofECMO. extremely high bi od loss in ECMO patients.
To date, no new pediatric RCTs are on the Despite these disa ointing study results, phy
horizon. Efforts in pediatrics became focused sicians such as Dr. uciano Gattinoni 42 and Dr.
on delineating optimal timing and indications Bartlett persevered~ ' its use in adults, reporting
for support, 36 pushing the envelope for pediatric significant surviva improvement compared to
indications,37,38 and determining relationships historical controls.
between center volumes and outcome. 39 Advances in E MO experience, equipment,
and expertise pave the way for another RCT in
Perseverance: Experience and Growing adult respiratory £~lure, i?e 2009 United King
Indications in Adult ECMO dom CESAR tri~, under the leadership ofDr.
Giles Peek.43 The ESAR trial took advantage
Since the initial efforts ofDr. Gibbon, clini of the regionalized ECMO system which had
cians sought to utilize the benefits of ECMO to allowed the success of the neonatal UK trial,
allow recovery in adult cardiac and respiratory with patients rand~mized to either remain at
failure. However, the road to acceptance of a standard treatmept center or be transferred
ECMO's benefit in adults was a slow one. The to a regional EC~O center. The study also
first attempt at an ECMO RCT was actually an utilized venovenou. (VV) cannulation, with its
NIH-supported adult trial directed by Zapol inherent advantage . Patients receiving care at
et al. comparing venoarterial (VA) ECMO to the ECMO center Idemonstrated significantly
standard therapy for severe respiratory fail improved intact sutival compared to standard
ure. 40 The study, while well intentioned, was center treatment. T re study results, while con
hampered by a variety of factors, including the troversial due to some method . . ita
choice of moribund patients for study entry, hons, served to sup ort the growing interest in
participation of the majority of centers with no adiilttherapeutic p tential.
previous ECMO experience, and the utilization The timing ofr lease ofthe CESAR results
ofVA cannulation patients potentially requiring shortly preceded e 2009 worldwide HINI
only respiratory support. The trial utilized the influenza pandemi~. The ;acute, severe, fulmi
relatively poor-performing technology available nant nature of res iratory failure with HINI
at the time, and lung protective strategies were led providers to se k ECMO as a therapeutic
not utilized in either ann. The study demon option, with encolaging findings supporting
strated very poor survival (approximately 10%) potential ECMO b nefit. 44,45 The convergence
in both study arms. These findings, although helped supercharg international growth of
clearly underlining the complexity of the clini ECMO use. Both E~SO Registry reports31 ,46 and
cal scenario (66% mortality in total population studies ofindepend,nt national data registries47
and 90% in severe ARDS patients), put a chill demonstrated a mar~ed rise in adult cannulation
on subsequent extension of ECLS in adult re in ~ubsequent year , with a continued upward
spiratory failure. trajectory to presen .
A later adult RCT in 199441 randomized This rise in us I of ex1racorporeal support
patients with ARDS to receive either extracor was fuelled by se~eral major advancements
poreal CO2 removal with VA support or stan in equipment, inc uding improvements in
9
Chapter 1
oxygenator components, ECLS circuit and removal opened th door for potential sup
configuration, and vascular access. Femoro port for a large num I er of adults with chronic
femoral cannulation with reduced cannula sizes, obstructive pulrnona disease'S ECMO teams
I
prevention of limb ischemia through selective also pushed the env lope in expanding indica
distal perfusion, active drainage of limb ve tions for extracorp~real support previously
nous flow, and attention paid to left ventricular considered contrain.~ications, wit~ reports of
unloading all played a critical role in enhanced
improved outcomes :~auma, malignancy, and
ECLS management, reduced complication sepsis on ECMO. 56,57 e use ofECLS for acute
rates, and improved outcome. Vascular access extracorporeal suppo during cardiopUlmonary
techniques transitioned from surgical cutdown resuscitation (ECPR)~ISO became a burgeoning,
and insertion towards emphasis on peripheral if somewhat controve sial indication for support,
access employing Seldinger technique, with with growing use in b th children and adults. 58-60
thin, small size, percutaneous cannulas, often
Global growth ~ECMO use has charac
characterized by nonthrombogenic surfaces. terized recent decad s. ECLS use in Europe
Cannula design (double lumen cannula for VV has been both longs ding and innovative. In
ECM0 48.49 or low profile cannula fQr arterial particular, the enhan~ed use in adult respira
access) and the routine application of a distal tory and cardiac fail r~ has been prop~gat~d
limb perfusion in case of femoral artery can in great part by exp nence and expertise m
nulation for peripheral venoarterial approach European centers. IntfmationaJ center growth
were additional breakthroughs for successful also resulted in the establishment of ELSO
ECMO application with significant reduction global chapters tied t o every continent. Eu-
in postprocedural complications. These in
novations increased use of VV cannula60n, Table 1-2. Chronol~~ v of Steering Committee
with transition to predominance ofVV use for Chairs-ELSa and Gl bal ELsa Chapters.
pediatric respiratory failure in 2012.31 Years Chair
Coating and heparin-bonded circuit sur- ELSO
2016-2018 Michael McMullan
faces,5o together with the miniaturization and
2014-2016 James Fortenbeny
integration of pump systems, led to the develop 2012-2014 William Lynch
ment of more simplified, portable, and efficient 2010-2012 Steve Conrad
ECLS systems. The most significant recent step 2007-2010 Mike Hines
2004-2007 Heidi Dalton
was the development ofthe polymethyl pentene 2002-2004 Joseph Zwischenberger
membrane oxygenator, which allowed achiev- 2000-2002 Ronald Hirschl
ing a low priming volumes, oxygenator pressure 1997-2000 Charles Stolar
1994-1997 Michael Klein
drop, high oxygenation efficiency, and long
1993-1994 Bill ie Lou Short
lasting membrane performance. 5l Preferential 1989-1993 Robert Bartlett
use ofcentrifugal pumps for pediatric and adult Euro ELSO
support also grew. 2014-2017 Roberto Lorusso
2012-2014 Giles Peek
Several trends in management also altered Asia Pacific ELSO
ECMO care. In Europe, efforts to allow pa 2013-2017 Graeme Maclaren
tients to remain awake and enhance mobility Latin American ELSO
2015-2017 I Luiz Caneo
were popularized, particularly by the ECMO
2013-2015 Rodrigo DiazJJavier Kattan
team at the Karolinska Institute,s2 allowing for I (Co-chairs)
longer runs, bridging for transplant, and the South aDd West Asia ELSO
2018 Venkat Goyal
capacity for ambulatory ECMO. 53 ,54 Primary 2017 Malaika Mendonca
use ofECMO for extracorporeai carbon dioxide 2014 -2016 Suneel Poobani
10
The History and Developm ent ofl:7xtracorporeal Support
roELSO was chartered in 2011 as a sequel to Table 1-3. Fello~ ship of the Extracorporeal
the previous European Extracorporeal Support Life Support Org2,nization: Members of Inau
gural Classes.
Organization (Table 1-2). Asia Pacific ELSO
soon followed, being chartered in 2013, and Inau2ural Class Members 2015
Latin American ELSO and the South and West Robert Bart ~tt MD
Asia ELSO chapters soon followed also in 2013, Konrad FaThe MD
all with the support ofthen-ELSO chair Steve Luciano Ga inoni NID
Conrad. These vibrant organizations allowed John Gibbo MD
accelerated growth of international ECMO Robert E. G oss MD
patient capture in the Registry, robust scientific J. Donald H II MD
conferences, expanded training courses, and Theodor (n d) Kolobow MD
Pearl O'Rou ke MD
enhanced global networking among ECMO
Billie Short VID
providers and centers. Individual membership
John Toom~ ian CCP
in ELSO was also initiated in 2016 to draw in C ass ofW16
members from around the world, whether or not Warwick Butt MD
their institution was an ELSO center. Robin Chap nan RN
The next chapter in the development of J. Devn Con ish MD
extracorporeal support remains to be written, Jean-Yves Chevalier MD
but it was the authors of the preceding works Richard Firmin MD
who set the stage. 10 2015, ELSO established Masahiro N~~ayo MD
Fellowship in the Extracorporeal Support Orga Giles Peek ~
nization, an honorary designation to recognize Antonio Pes nti MD
Peter Rycus fvn>H
these pioneering contributors to the ECMO
Charles Stol ~ MD
story (Table 1-3). Much more work remains to
Warren Zap< I MD
be done to improve ECMO technology, predict Joseph (Jay) ~wischenberger MD
outcomes, and fine tune best indications. 47 ,61 As
we seek to fulfill Dr. Gibbons' quest for lifesav
ing support, we should be encouraged by the
inspiring words of Sir Winston Churchill, "The
future is unknowable, but the past should give
-
us hop~'62
11
Another random document with
no related content on Scribd:
Repeat the same procedure the next day. Vary the introduction
somewhat, like this: “I want you to do this just as you did yesterday,
except that I want this margin over here on the right side to be on a
straight line. Wait till I take this ruler and show you.” Lay the ruler
lengthwise of the sheet you want the pupil to write on, so that you
can take your lead pencil and make a line about an inch from the
right side of the page. “Now, when you have written out to this line
here, then stop and begin on the next line like this:” (show the child
how you write a sentence and begin on the next line). It would be
well if the sentence which you use as an example were to be one that
would express some familiar thought about the child’s immediate
interests, such as his favorite sport. Leave the child’s desk as you
were advised to leave it the day before and also return as before and
approve that which the pupil does well, either saying absolutely
nothing about the careless parts or suggest incidently that the pupil
could help such and such a part by doing this or that thing to it. Be
sure to end your remarks by some such expression as, “That’s good,”
or “That’s fine.”
(3) Learning to Draw. Not infrequently it Lower Grades
happens that a pupil comes into school who
has never learned to draw and who, feeling his inability to
accomplish the task set for him in the drawing lesson, refuses to
make any attempt to do so. Especially is this true if the picture is to
be drawn from imagination. In such a case it is best to begin with
copying. When this art is learned, drawing from imagination will be a
comparatively easy step.
For example, choose a very simple picture for the child to
reproduce on another piece of paper. It is a good plan for a teacher to
have at least a dozen or more pictures in one drawer of his desk all
the time, because many pupils like to draw and copy pictures and it
is an excellent way to get them interested in other work. Present the
picture of some ordinary scene. Tell the pupil before he begins that
you are going to make a collection of pictures which your pupils
draw. The picture need not have much life in it to start with, but right
here we make use of the child’s imagination to wonderful advantage.
Suppose the picture, which you have in hand, shows a tree or two, a
house, a couple of bushes or any kind of natural objects whatsoever.
Talk to the pupil in this fashion, pointing to different parts of the
picture with your pencil and have your face near the picture,
indicating interest and enthusiasm as you talk: “Now, right behind
this tree here, I want you to draw a boy, sticking his head out from
behind the tree. And right over here, where I make this little cross
mark, I want you to draw a little girl hiding behind this bush. We will
suppose they are playing ‘Hide and Seek.’ Right over here, between
this tree and the house, draw a boy’s hat. Maybe he has lost it while
he was running to hide. You know how to make a hat. Just like this:”
(draw a very simple hat, merely making a straight line and a semi-
circle connecting two points in it.) “Maybe you can draw a better one
than that. I’ll come back to your desk pretty soon and see what kind
of a hat you drew and also that little boy sticking his head out from
behind the tree. Is your pencil sharp enough?”
The child will say that his pencil is all right. Then leave him at once
and in ten or fifteen minutes return. Go back with this one thought in
mind, that you will say nothing at all except that which is
complimentary. For example, say, “Well, I should say you can draw. I
believe you made a better hat than I did. Now this afternoon, I am
going to give you something else to draw. Maybe a pony with a boy
on his back and a girl riding in the pony cart. You are going to be
good at drawing things for me, I know. I want to keep all of your
drawings after you have finished them for me.”
In case the child should interrupt and ask to draw the pony right
away instead of waiting until afternoon, answer by saying, “I will
have the picture ready for you after dinner and then I will bring it to
you.”
Of course, it is not necessary to use the exact words we have
suggested, or to use the same pictures or even to use pictures at all.
The important point is to offer something that is at once interesting
in order to get the pupil started in drawing. Do not insist much upon
regular lessons during the first day or two in which your chief
problem is to get the pupil’s confidence.
After the child has learned to like to do the things which you
suggest present more difficult, or even purely imaginative, subjects
for drawing.
Use the same method in getting the child to take an interest in
other subjects than drawing—that is, give him very small tasks, then
approve and compliment him on his ability. This will bring good
results with any pupil who is normal.
As a transition step between mere copying and drawing wholly
from the imagination, and also to give the timid child confidence
enough to come to the blackboard to draw in the presence of other
children, the following might be tried.
Having the confidence of the little pupil, go to his desk just before
school closes in the evening and say, “I would like for you to stay just
a moment after school. I want to tell you something.”
After most of the pupils have marched out, return to his desk,
begin to talk enthusiastically about a picture which you have. Tell
him to follow you and you will try to draw it. Then after reaching the
blackboard and picking up a piece of crayon, say, “Now, I am going
to draw this man’s face and I want you to draw his eyes.” Let it take
you about a minute to draw the outline of the man’s face, talking all
the time about how well you like to draw pictures, then say, “Now
let’s see if you can draw his eyes. Make a mark right there” (point to a
spot). “Good! Now draw his other eye. Good! Now his ear. Make a
mark right here” (point to a spot). “My, that’s fine. See, what a fine
man you drew.” Start to leave the blackboard and say, “I’m going to
have you draw for me again.”
Repeat this process every day until you feel sure that the child will
go to the blackboard and work in the presence of yourself and the
class.
DIVISION VII
Only through the gateway of personal experience does the child enter into the
larger understanding of the thought and achievement of humanity.
CASES ARISING OUT OF THE SOCIAL
INSTINCTS
CONSTRUCTIVE TREATMENT
There are occasions when a definite issue for the mastery occurs in
the school-room, and this was one of them. Miss Nelson had no right
to break her promise to a docile and obedient child, and reinforce the
habitual selfishness of a spoiled one. She should have insisted that
Karen take her turn with the rest, and if Karen had stormed it would
have given her a good opportunity to show her that her usual
methods would not work in school. The angry storming of a spoiled
child is usually done with an alert eye to the effect produced on the
audience; therefore, if Karen had wept and wailed, she should have
been carried out into the hall, where she might have been left in
lonely state to recover her good temper. Usually one or two such
trials convince a spoiled child that he has met his match, and if such
children are followed by tactful guidance, and especially if attention
can be diverted away from themselves, the worst-spoiled children
can in time be thoroughly socialized.
COMMENTS
ILLUSTRATION (KINDERGARTEN)
CONSTRUCTIVE TREATMENT
When children are not supplied with the necessary equipment for
their work and are too poor to buy for themselves make an appeal to
the board of education asking them to purchase the material needed,
which material should be considered the property of the school and
left there from year to year. Most states require that the school
furnish books and equipment for all who are unable to buy them.
Show by your own example that poor people are just as desirable
for companions as rich ones, other things being equal. See to it that
the children of poor parents be made to forget, while at school, that
they are different from others. See to it that democracy reigns on the
playground.
Supervise all play.
Do not foster the borrowing habit.
COMMENTS
CONSTRUCTIVE TREATMENT
Miss Bush was too superficial in her original treatment of this case.
She had had ample time to think out a workable plan that would
have caused no friction.
After having all food removed from the desks she might have asked
the pupils to find appropriate seats in which to eat their lunches.
After lunch time she should have led the way to the playground
where all else than play would be easily forgotten.
From time to time short talks on manners should be given to the
whole school.
COMMENTS